Nikitar Rizky Arimami 030.08.180 Pembimbing: dr. Zuhriyah Hidajati Sp.A Pendahuluan • Infeksi yang disebabkan pneumokokus adalah penyebab angka kesakitan (morbiditas) dan…
Pneumococcal Conjugate Vaccine Pneumococcal Conjugate Vaccine Edward wijaya 030.08.089 Pembimbing: dr. Slamet widi, spA Pendahuluan Infeksi yang disebabkan pneumokokus adalah…
1 ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI 2 1. DENUMIREA COMERCIALĂ A MEDICAMENTULUI Synflorix suspensie injectabilă în seringă preumplută Synflorix suspensie…
1 ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 2 1. DENOMINAZIONE DEL MEDICINALE Prevenar 13 sospensione iniettabile Vaccino pneumococcico polisaccaridico coniugato,…
Slide 1Cancun December 10, 2013 Claire Broome, MD [email protected] • Summarize discussion and conclusions from September 2013 meeting of global technical experts and
7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 020 7418 8400 Facsimile +44 020 7523 7455 E-mail info@emaeuropaeu Website wwwemaeuropaeu…
1 ANEXO I FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO 2 1. NOMBRE DEL MEDICAMENTO Prevenar 13 suspensión inyectable Vacuna antineumocócica polisacárida…
ACIP-20-valent Pneumococcal Conjugate Vaccine (PCV20) Phase 3 in Adults-February, 202120-valent Pneumococcal Conjugate Vaccine (PCV20) Phase 3 in Adults Wendy Watson, MD
against Radiographically-confirmed Pneumonia of Age in South Africa Ahmed Mohamed Mahmoud Elamin University of the Witwatersrand, in partial fulfilment of the requirements
ABSTRACT Introduction: The CAPiTA study, which was a randomized, double-blind clinical trial in 84,496 participants 65 years of age and older in the Netherlands, demonstrated
Seven-valent pneumococcal conjugate vaccine PCV- 7 is effective against vaccine serotype disease and car- riage. Nevertheless, shifts in colonization and disease to- ward…
PHE publications gateway number: GW-1012 Pneumococcal polysaccharide conjugate vaccine 13-valent adsorbed Patient Group Direction PGD This PGD is for the administration of…
1 ANEXO I FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO 2 1. NOMBRE DEL MEDICAMENTO Prevenar 13 suspensión inyectable Vacuna antineumocócica polisacárida…
1 Pneumococcal Conjugate Vaccine PCV Product Assessment April 2017 Olivia Cohen Contact: Kate O’Brien MD MPH Executive Director IVAC Johns Hopkins Bloomberg School of Public…
Seven-valent pneumococcal conjugate vaccine (PCV- 7) is effective against vaccine serotype disease and car- riage. Nevertheless, shifts in colonization and disease to- ward…
198-pneumo-report-final-070810.doc i 10/10/2007 Vaccine presentation for pneumococcal conjugate vaccines GAVI Vaccine Presentation and Packaging Advisory Group: Interim Report…
An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) â Statement on the Use of Conjugate Pneumococcal Vaccine â 13 valent in Adults…
Impact of the pneumococcal conjugate vaccine in South Africa Anne von Gottberg Centre for Respiratory Diseases and Meningitis (CRDM) Mortality due to pneumonia • South…
0 Pneumococcal Conjugate Vaccine: Supply and Demand Update UNICEF Supply Division July 2020 1 Pneumococcal Conjugate Vaccine Supply and Demand Update July 2020 1 Summary…
www.ncirs.usyd.edu.au Pneumococcal conjugate vaccine impact and schedule arithmetic: 3+0 vs 3+1 vs 2+1 Peter Mcintyre National Centre for Immunisation Research Australia…